Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Co... Simple Summary: Pembrolizumab monotherapy remains the first-line standard of care for patients with metastatic NSCLC and a PD-L1 tumor propo...
靶点 公司最常开发的靶点 疾病领域数量 肿瘤 3 内分泌与代谢疾病 1 感染 1 排名前五的药物类型数量 小分子化药 2 诊断用放射药物 2 核素偶联药物 1 多肽偶联核素 1 排名前五的靶点数量 GRPR(胃泌素释放肽前体受体) 1 PDL1(程序性死亡配体1) 1 αvβ6(整合素α-V/β-6复合体) 1 ...
aPlease tslk to your doctor to give ou s new drug listed on the Affinity Health Plan Preferred Drug List (PDL),such as a preferred drug which can be found on the Affinity PDL at www.affinityplan.org or by calling CVS Caremark Customer care at (855)-465-0031. 正在翻译,请等待...[...
aPlease tslk to your doctor to give ou s new drug listed on the Affinity Health Plan Preferred Drug List (PDL),such as a preferred drug which can be found on the Affinity PDL at www.affinityplan.org or by calling CVS Caremark Customer care at (855)-465-0031. 正在翻译,请等待...[...
tIondeemepdl,olyocsaklilelmedpllaobyomuernftroismsethene masicarov-aelnuvaibrolenmtoeonl tininpwrohviicdhinthgevyaolupeercarteea(tcioonm, msuupnpitoyr,trfeogriotnh)e. Ipnrdoegerdes, slioocnalanemd pulpogyrmadeinntgisofseseknillassaandvailnuvaebsltemteonotl iinn epdruovcaidtiionng avnad...